BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16533399)

  • 1. Studies on the synthesis, characterization, binding with DNA and activities of two cis-planaramineplatinum(II) complexes of the form: cis-PtL(NH3)Cl2 where L = 3-hydroxypyridine and 2,3-diaminopyridine.
    Abdullah A; Huq F; Chowdhury A; Tayyem H; Beale P; Fisher K
    BMC Chem Biol; 2006 Mar; 6():3. PubMed ID: 16533399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and binding with DNA of four planaramineplatinum(II) complexes of the forms: trans-PtL2Cl2 and [PtL3Cl]Cl, where L = 3-hydroxypyridine, 4-hydroxypyridine and imidazo(1,2-alpha)pyridine.
    Chowdhury MA; Huq F; Abdullah A; Beale P; Fisher K
    J Inorg Biochem; 2005 May; 99(5):1098-112. PubMed ID: 15833333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models.
    Deqnah N; Qing Yu J; Beale P; Fisher K; Huq F
    Med Chem; 2013 Jun; 9(4):539-44. PubMed ID: 23061563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on activities, cell uptake and DNA binding of four trans-planaramineplatinum(II) complexes of the form: trans-PtL(NH3)Cl2, where L=2-hydroxypyridine, imidazole, 3-hydroxypyridine and imidazo(1,2-alpha)pyridine.
    Huq F; Yu JQ; Daghriri H; Beale P
    J Inorg Biochem; 2004 Aug; 98(8):1261-70. PubMed ID: 15271501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterisation, activities, cell uptake and DNA binding of a trinuclear complex: [[trans-PtCl(NH3)]2mu-[trans-Pd(NH3)(2-hydroxypyridine)-(H2)N(CH2)6NH2)2]Cl4.
    Cheng H; Huq F; Beale P; Fisher K
    Eur J Med Chem; 2006 Jul; 41(7):896-903. PubMed ID: 16730394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the synthesis and characterization of four trans-planaramineplatinum(II) complexes of the form trans-PtL(NH3)CL2 where L = 2-hydroxypyridine, 3-hydroxypyridine, imidazole, and imidazo(1,2-alpha)pyridine.
    Huq F; Daghriri H; Yu JQ; Beale P; Fisher K
    Eur J Med Chem; 2004 Aug; 39(8):691-7. PubMed ID: 15276302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
    Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
    Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH(3))}(2)mu-{trans-Pt(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4).
    Cheng H; Huq F; Beale P; Fisher K
    Eur J Med Chem; 2005 Aug; 40(8):772-81. PubMed ID: 16122580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism from combination of cisplatin and a trans-platinum compound in ovarian cancer cell lines.
    Alshehri A; Beale P; Yu JQ; Huq F
    Anticancer Res; 2010 Nov; 30(11):4547-53. PubMed ID: 21115904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterisation, activities, cell uptake and DNA binding of [[trans-PtCl(NH3)2] [mu-(H2N(CH2)6NH2)] [trans-PdCl(NH3)2](NO3)Cl.
    Huq F; Daghriri H; Yu JQ; Tayyem H; Beale P; Zhang M
    Eur J Med Chem; 2004 Nov; 39(11):947-58. PubMed ID: 15501544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
    Tayyem H; Huq F; Yu JQ; Beale P; Fisher K
    ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumour activity of a new trinuclear platinum compound [{cis-PtCl(NH3)2μ {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] Cl4 in human ovarian cancer cells.
    Hamad SA; Beale P; Yu JQ; Huq F
    Anticancer Res; 2014 Apr; 34(4):1923-9. PubMed ID: 24692727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the activity of two Trans-planaramine platinum(II) complexes coded as DH4 and DH5 in human ovarian tumour models.
    Deqnah N; Yu JQ; Beale P; Huq F
    Anticancer Res; 2012 Dec; 32(12):5331-6. PubMed ID: 23225434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
    Lippert B
    Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
    Comess KM; Burstyn JN; Essigmann JM; Lippard SJ
    Biochemistry; 1992 Apr; 31(16):3975-90. PubMed ID: 1314653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+.
    Balcarová Z; Kaspárková J; Zákovská A; Nováková O; Sivo MF; Natile G; Brabec V
    Mol Pharmacol; 1998 May; 53(5):846-55. PubMed ID: 9584210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
    Bierbach U; Sabat M; Farrell N
    Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, activity and binding with DNA of [{trans-PtCl(NH(3))(2)}(2)micro-{trans-Pd(4-hydroxypyridine) (2) (H(2)N(CH(2))(6)NH(2))(2)]Cl(4) (TH8).
    Huq F; Tayyem H; Yu JQ; Beale P; Fisher K
    Med Chem; 2009 Jul; 5(4):372-81. PubMed ID: 19689395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism from combination of cisplatin and multicentred platinums coded as DH6Cl and TH1 in the human ovarian tumour models.
    Alshehri A; Beale P; Yu JQ; Huq F
    Med Chem; 2011 Nov; 7(6):593-8. PubMed ID: 22313299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
    Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ
    Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.